Mercer Global Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Buy
44,570
+11,910
+36% +$149K ﹤0.01% 2009
2025
Q4
$422K Buy
32,660
+4,124
+14% +$52.9K ﹤0.01% 1984
2025
Q3
$369K Buy
28,536
+15,160
+113% +$203K ﹤0.01% 1947
2025
Q2
$238K Buy
+13,376
New +$233K ﹤0.01% 1992
2022
Q2
Sell
-3,267
Closed -$271K 1890
2022
Q1
$271K Buy
3,267
+496
+18% +$36.5K ﹤0.01% 1564
2021
Q4
$208K Sell
2,771
-321
-10% -$32.2K ﹤0.01% 1642
2021
Q3
$359K Buy
3,092
+239
+8% +$36.1K ﹤0.01% 1340
2021
Q2
$633K Buy
2,853
+697
+32% +$136K ﹤0.01% 1031
2021
Q1
$285K Buy
+2,156
New +$341K ﹤0.01% 1331

Other funds holding NVCR